Key result
Low-dose propranolol reduced supraventricular tachyarrhythmias compared to control after coronary artery bypass grafting, whereas diltiazem was ineffective.
Why the study?
Does prophylactic low-dose propranolol or diltiazem reduce the occurrence of supraventricular tachyarrhythmia in patients after coronary artery bypass grafting?
RCT (n=103)
prospective
Does prophylactic low-dose propranolol or diltiazem reduce the occurrence of supraventricular tachyarrhythmia in patients after coronary artery bypass grafting?
Low-dose propranolol is an effective and safe prophylaxis for preventing supraventricular tachyarrhythmias after CABG, whereas diltiazem is ineffective and increases the need for inotropic support.
Answers are grounded in this paper and cite their sources.
Propranolol prophylaxis warrants consideration after CABG; confirms beta-blocker efficacy and challenges diltiazem in arrhythmia prevention.
OBJECTIVE: Supraventricular tachyarrhythmias (SVT) complicate postoperative management after coronary bypass surgery in about 30% of all patients. Though a prophylactic treatment both with beta-adrenergic blocking agents and the calcium antagonist diltiazem has been used for the prevention of post-operative SVT, no study yet has performed a prospective comparison of the efficacy of these therapies. METHODS: To investigate the prophylactic effect of either a calcium antagonist (diltiazem, 0.1 mg/kg per h i.v.) or a beta-adrenergic blocking agent (propranolol, 10 mg every 6 h postoperatively), we randomized prospectively 103 consecutive patients into three groups, the third one serving as a control group. Anti-arrhythmic medication was started with the procedure and was continued until the 3rd postoperative day. RESULTS: Preoperative conditions were the same for the three groups concerning age, extent of coronary heart disease, ventricular function and heart-related medication. There were no differences in intraoperative parameters or postoperative enzyme patterns. Diltiazem was ineffective in preventing SVT, the incidence being exactly the same as in the control group (35%). Propranolol reduced the occurrence of SVT significantly (7%, P < 0.05). Furthermore, patients treated with diltiazem needed positive inotropic support more often in the first hours after surgery than patients of the control group (30% vs 5%, P < 0.01). CONCLUSIONS: The perioperative administration of low-dose propranolol is considered a safe and effective drug prophylaxis to avoid the occurrence of SVT after bypass surgery.
No takes yet. Share an insight, caveat, or question.
Babin-Ebell et al. (1996) conducted an RCT in Supraventricular tachyarrhythmia after coronary artery bypass grafting (n=103). Propranolol or Diltiazem vs. Control group was evaluated on Occurrence of supraventricular tachyarrhythmias (SVT) (p=< 0.05). Low-dose propranolol reduced supraventricular tachyarrhythmias compared to control after coronary artery bypass grafting, whereas diltiazem was ineffective.
Synapse has enriched 10 related papers. Consider them for comparative context: